4,7-dichloroquinoline

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

1.	Cerebral Malaria 01/01/2017 - "The study aimed to investigate in a mouse model of human cerebral malaria whether a trioxaquine chemically synthesized by covalent linking of a 4,7-dichloroquinoline pharmacophore to artesunate through a recent drug development approach termed 'covalent bitherapy' could improve the curative outcomes in cerebral malaria infections. "
2.	Infections 01/01/2017 - "Also, 4,7-dichloroquinoline and quinine did not show any significant parasitaemia suppression in the first 24 h post-treatment, with the animals succumbing to the infection. " 01/01/2017 - "The study aimed to investigate in a mouse model of human cerebral malaria whether a trioxaquine chemically synthesized by covalent linking of a 4,7-dichloroquinoline pharmacophore to artesunate through a recent drug development approach termed 'covalent bitherapy' could improve the curative outcomes in cerebral malaria infections. "
3.	Allergic Contact Dermatitis 07/01/1982 - "Allergic contact dermatitis from 4,7-dichloroquinoline."